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Background: Various degrees of hemodilution are currently in clinical use 
during deep hypothermic circulatory arrest o counteract deleterious rheologic 
effects linked with brain injury by previous reports. Material and methods: 
Seventeen piglets were randomly assigned to three groups. Group I piglets 
(n = 7) received colloid and crystalloid prime (hematocrit < 10%), group II 
piglets (n = 5) received blood and crystalloid prime (hematocrit 20%), group 
I I I  piglets (n = 5) received blood prime (hematocrit 30%). All groups 
underwent 60 minutes of deep hypothermic circulatory arrest at 15 ° C. with 
continuous magnetic resonance spectroscopy and near-infrared spectroscopy 
Neurologic recovery was evaluated for 4 days (neurologic deficit score 0, 
normal, to 500, brain death; overall performance category 1, normal, to 5, 
brain death). Neurohistologic s ore (0, normal, to 5+, necrosis) was assessed 
after the animals were euthanized on day 4.  Results: Group I had significant 
loss of phosphocreatine and intracellular acidosis during early cooling (phos- 
phocreatine in group I, 86.3% - 26.8%; group II, 117.3% -+ 8.6%; group III, 
110.9% - 2.68%;p = 0.0008; intracellular pH in group I, 6.95 - 0.18; group II, 
7.28 -+ 0.04; group HI, 7.49 + 0.04; p - 0.0048). Final recovery was the same 
for all groups. Cytochrome aa 3 was more reduced in group I during deep 
hypothermic irculatory arrest than in either of the other groups (group I, 
-43.6 - 2.6; group II, -16.0 -- 5.2; group I l l ,  1.3 _+ 3.1; p < 0.0001). 
Neurologic deficit score was best preserved in group I l l  (p < 0.05 group II vs 
group HI) on the first postoperative day, although this difference diminished 
with time and all animals were neurologically normal after 4 days. Histologic 
assessment was worst among group I in neocortex area (group I, 1.33 - 0.3; 
group II, 0.22 - 0.1; group III, 0.40 _+ 0.2, p < 0.05, group I vs group II; p = 
0.0287, group I vs group I l l).  Conclusion: Extreme hemodilution during 
cardiopulmonary b pass may cause inadequate oxygen delivery during early 
cooling. The higher hematocrit with a blood prime is associated with improved 
cerebral recovery after deep hypothermic circulatory arrest. (J Thorac Cardio- 
vasc Surg 1996;112:1610-21) 
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H emodilution has been widely applied for hypo- 
thermic cardiopulmonary bypass (CPB) for 
many years. It was first introduced to decrease 
homologous blood use, 1 thereby avoiding the "ho- 
mologous blood syndrome. ''2 Later, the effects of 
hemodilution i  counteracting the deleterious rheo- 
logic consequences of deep hypothermia, such as 
increased viscosity and red cell rigidity, came to be 
considered important in minimizing brain injury 
associated with deep hypothermic circulatory arrest 
(DHCA). 3 However, hemodilution reduces the ox- 
ygen carrying capacity of blood. In combination with 
the leftward shift of the oxyhemoglobin dissociation 
curve induced by hypothermia, which may be further 
exacerbated by an alkaline pH strategy such as 
alpha-stat, hemodilution may critically limit oxygen 
delivery to neurons and other cells. 4 
Until recently, it was not possible to directly 
examine the adequacy of oxygen delivery to neurons 
during CPB. Both clinical and laboratory studies 
have used surrogate end points, such as gross evi- 
dence of neurologic injury or measurement of cere- 
bral blood flow or cerebral metabolic rate. Recent 
developments in magnetic resonance spectroscopy 
(MRS) and near infra-red spectroscopy (NIRS) 5 
now allow more direct investigation of the adequacy 
of oxygen delivery to cerebral cells and the ability of 
cells to synthesize and maintain high-energy phos- 
phates. We developed a piglet survival model of 
DHCA that includes imultaneous MRS and NIRS, 
followed by evaluation of neurologic status for 4 
days and ending with the sacrifice and histologic 
assessment of the animal. We used the model in this 
study to evaluate the neurologic effects of perfusate 
hematocrit during DHCA under conditions imilar 
to those used clinically. 
Consistent with a lack of firm data from the past 
on which to base a strategy for hematocrit manipu- 
lation during DHCA is the observation that widely 
disparate protocols have evolved at different centers 
undertaking high volumes of neonatal and infant 
cardiac operations. 6 At Loma Linda University, a 
blood-free prime is routinely applied for neonatal 
DHCA, resulting in a hematocrit less than 10%. 7 
Colloid osmotic pressure is elevated by means of 
albumin. At Children's Hospital in Boston, a mix- 
ture of whole blood (not packed cells) and crystal- 
loid solution is used for the prime to achieve an 
hematocrit of 20% during CPB. s No colloid other 
than the plasma in the whole blood is added. At 
Marie-Lannelongue in Paris, a blood-only prime is 
used to achieve an hematocrit greater than 30%. 9 
Our study examines the adequacy of cerebral pro- 
tection afforded by these three hemodilution proto- 
cols. 
Methods 
Experimental preparation. Seventeen 5-week-old 
Yorkshire piglets, weight 6.2 to 8.8 kg (mean 7.9 kg), were 
anesthetized with intraperitoneal sodium methohexital 
(45 mg/kg) and intubated with a 5 mm cuffed endotracheal 
tube. Each animal was ventilated at a peak inspiratory 
pressure of 20 cm H20, an inspired oxygen fraction of 
0.21, and a rate of 12 breaths/min, by means of a pressure 
control ventilator (Healthdyne model 105; Healthdyne 
Technologies, Marietta, Ga.) to achieve anormal pH and 
arterial carbon dioxide tension. After an intravenous 
bolus of fentanyl (25 /xg/kg) and pancuronium (0.5 rag/ 
kg), anesthesia was maintained by a continuous infusion 
of fentanyl (25 /xg.kg 1.hr-1), midazolam (0.2 
mg. kg 1. hr-a), and pancuronium (0.2 mg/kg), 
throughout the entire experiment except during the pe- 
riod of circulatory arrest. Esophageal temperature was 
recorded continuously until extubation. Before operation, 
a 3.0 cm diameter surface coil for MRS was sutured on the 
scalp overlying the cerebral hemispheres, and a pair of 
fiberoptic optodes for NIRS were applied to the head over 
the frontal lobes with an interoptode distance of 3 cm. The 
superficial left femoral artery was cannulated for arterial 
blood pressure monitoring and blood gas sampling. The 
right femoral artery was exposed for the CPB arterial 
cannula. A right anterolateral thoracotomy was per- 
formed in the third intercostal space to expose the right 
atrium for venous cannulation. 
After systemic heparinization (300 IU/kg), an 8F Bio- 
Medicus arterial cannula (Medtronic Bio-Medicus, Min- 
neapolis, Minn.) and 24F venous cannula (Bard, Inc., 
USCI Division, Billerica, Mass.) were inserted into the 
right femoral artery and right atrium, respectively. The 
animal was then placed in a MRS horizontal-bore super- 
conducting 4.7 magnet (Oxford Research System, Oxford, 
England) and subjected to CPB and DHCA, as deter- 
mined by the protocol (Fig. 1). 
After 45 minutes of rewarming, the piglet was weaned 
from CPB and decannulated outside the MRS bore. 
Protamine (5 mg/kg) was administered intravenously. 
Immediately after decannulation, the animal was reposi- 
tioned in the bore for 3 hours for MRS and NIRS data 
collection. After that, all incisions were closed in a sterile 
fashion. The animal remained intubated uring the first 
12 postoperative hours. 
All animals received humane care in compliance with 
the "Principles of Laboratory Animal Care" formulated 
by the National Society for Medical Research and the 
"Guide for the Care and Use of Laboratory Animals" 
prepared by the Institute of Laboratory Animal Resources 
and published by the National Institutes of Health (NIH 
publication No. 86-23, revised in 1985). 
Experimental groups. Piglets were randomly assigned 
to three groups. Group I (n = 7, extreme hemodilution) 
received colloid and crystalloid priming with a hematocrit 
lower than 10%. The prime consisted of 800 ml Normosol 
R, pH 7.4 (Abbott Laboratories, North Chicago, Ill.), and 
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Fig. 1. Flow diagram depicting experimental protocol. T.Bil, Total bilirubin. 
400 ml Hetastarch (Hespan; Du Pont Companies, Wil- 
mington, Del.). Group II (n = 5) was moderately hemodi- 
luted with 400 ml blood and 800 ml crystalloid solution 
(Normosol R, pH 7.4) with a hematocrit of 20%. Group 
III (n = 5, no hemodilution) was prepared with 1200 ml 
whole-blood prime and a hematocrit of 30%. 
CPB technique. The circuit consisted of a roller pump 
(Cardiovascular Instrument Corp., Wakefield, Mass.), 
membrane oxygenator (VPCML plus; COBE Cardiovas- 
cular, Inc., Arvada, Colo.), and sterile tubing (Olson 
Medical Sales, Inc., Ashland, Mass.), with a 40 p~m arterial 
filter (Pediatric extracorporeal b ood filter; PALL Bio- 
medical, Inc., East Hills, N.Y.). The pump prime was 
determined by the experimental protocols described pre- 
viously. Cefazolin sodium (25 mg/kg), methylprednisolone 
sodium succinate (30 mg/kg), furosemide (0.25 mg/kg), 
and sodium bicarbonate (f0 ml) were added to the prime. 
Full bypass flow was set at 100 ml • kg -a • rain -1. After 
cannulation and connection of the CPB circuit, animals 
were placed in the magnet bore for measurement of 
baseline MRS and NIRS data. CPB was then commenced 
and animals were immediately cooled to an esophageal 
temperature of 15°C during a 40-minute period by the 
pH-stat strategy. Phentolamine mesylate (0.2 mg/kg) was 
administered before cooling. Ventilation was stopped 
after the establishment of CPB. 
On reperfusion, furosemide (0.25 mg/kg), mannitol (0.5 
g/kg), phentolamine (0.2 mg/kg), and sodium bicarbonate 
(10 ml) were administered into the pump. The animal was 
warmed to a temperature of 35°C during a 45-minute 
period, maintaining a flow rate of 100 ml. kg -~ • rain 1. 
The heart was defibrillated as necessary at 25 ° C. Fresh 
whole blood from a donor pig, drawn on the day of 
operation, was transfused into the pump as required to 
increase hematocrit to at least 25% in all groups during 
rewarming. In addition, ultrafiltration with a hemocon- 
centrator (Hemocor HPH 400; Minntech Corp., Minne- 
apolis, Minn.) was performed uring reperfusion i  group 
I to achieve this hematocrit. Ventilation was restarted 10 
minutes before weaning from CPB with an inspired 
oxygen fraction of 1.0. The animal was then weaned from 
CPB and decannulated outside the bore. Intravenous 
protamine was administered when the animal was in 
hemodynamically stable condition. After decannulation, 
the animal was repositioned in the bore for a further 3 
hours of MRS and NIRS data collection. 
Postoperative management. All animals remained se- 
dated, paralyzed, mechanically ventilated, and monitored 
continuously for 12 hours after operation, at which time 
chest tubes were removed, infusions were discontinued, 
and the animals were weaned from ventilation and extu- 
bated. Hemodynamic stability was observed in all animals, 
and none required postoperative inotropic or vasopressor 
support. 
Data collection 
Spectroscopy. Details of MRS TM and NIRS 11 have been 
described previously elsewhere. 
Biochemical analysis. Blood samples were taken on the 
day after the operation. Aspartate transaminase (AST), 
alanine transaminase (ALT), lactate dehydrogenase 
(LDH), alkaline phosphatase (ALP), creatine kinase 
(CK), and total bilirubin were measured. 
Other evaluations. Details of methods employed for 
neurologic and behavioral evaluations (neurologic deficit 
score [NDS] and overall performance category [OPC]) 
and for histologic evaluations have been described previ- 
ously elsewhere) 2' a3 
Statistical analysis. All results were expressed as mean 
(_+ standard error of the mean) and analyzed by a 
statistical analysis software package (Stat-View version 
4.5, Abacus Concepts, Berkeley, Calif.). Analysis of variance 
and Bonferroni test were used to analyze the MRS data, 
NIRS data, enzyme deficits, and NDSs among and between 
groups. Kruskal-Wallis and Mann-Whitney tests were used 
for analysis of the OPC and histologic score. Ap  value less 
than 0.05 was considered statistically significant. 
Results 
Experimental conditions. The experimental con- 
ditions for each group are shown in Table I. Animals 
were similar in size, and there were no differences in 
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Table I. Experimental conditions 
Group I Group H Group lII 
(mean ± SEM) (mean +_ SEM) (mean +- SEM) ANOVAp 
Significant difference 
(p < 0.05) 
I vsH IIvs III III vs I 
Body weight (kg) 8.03 2 0.20 7.43 _+ 0.34 8.13 ± 0.26 0.0800 
Hematocrit (%) 
Before operation 27.33 ± 1.43 27.63 + 1.12 29.80 _+ 1.39 0.3145 
Prime 0.00 + 0.00 13.63 +_ 0.53 28.80 -+ 0.86 <0.0001 
Before CA 8.44 ± 0.75 19.75 -+ 0.46 31.00 ± 0.63 <0.0001 
Before CPB weaning 27.44 ± 0.75 25.63 ± 0.75 30.20 _+ 0.66 0.0004 
POD1 29.00 +__ 0.57 29.67 _+ 1.15 30.20 _+ 0.66 0.5855 
Esophagus temperature (°C) 
During cooling 
0 min 34.48 ± 0.82 33.85 ± 0.63 34.12 ± 0.42 0.7032 
40 min 14.12 2 0.40 14.04 _+ 0.40 14.63 ± 0.31 0.5251 
During rewarming 
0 rain 15.81 ± 0.60 16.79 _+ 0.62 15.53 -+ 0.40 0.2259 
45 rain 34.97 ± 0.47 35.43 ± 0.46 35.12 ± 0.24 0.6192 
Perfusion pressure (ram Hg) 
During cooling 
10 min 30.13 ± 3.77 47.88 ± 6.93 87.60 -+ 3.96 <0.0001 
20 min 27.00 + 3.16 47.63 ± 5.89 85.20 ± 2.08 <0.0001 
30 min 26.38 + 2.39 46.38 -+ 5.53 89.60 ± 2.58 <0.0001 
40 rain 25.63 ± 2.27 45.38 ± 5.27 81.20 ± 4.68 <0.0001 
During rewarming 
10 min 33.75 ± 4.98 35.13 ± 4.07 41.00 ± 1.92 0.3340 
20 min 46.50 ± 8.24 40.13 ± 4.78 53.60 _+ 4.27 0.0417 
30 rain 67.13 _+ 11.18 66.25 +_ 10.54 62.00 ± 6.22 0.9093 
40 min 77.13 +_ 9.51 75.00 ± 8.21 78.20 -+ 6.79 0.9467 
Ca (mmol/L) 
During cooling, 20 min 0.83 ± 0.05 1.04 ± 0.05 1.39 _+ 0.05 <0.0001 
During rewarming, 20 min 1.08 -+ 0.03 1.12 ± 0.05 1.45 +_ 0.09 0.0001 
Osmolarity (mOsm) 
Pump prime 270.71 ± 0.93 283.00 +_ 2.87 280.60 _+ 2.79 0.0008 
After pump 280.33 ± 1.58 281.67 ± 2.27 277.20 +_ 3.06 0.3976 
<0.0001 <0.0001 <0.0001 
<0.0001 <0.0001 <0.0001 
<0.0001 <0.0001 <0.0001 
0.0152 0.0001 <0.0001 
0.0025 <0.0001 <0.0001 
0.0021 <0.0001 <0.0001 
0.0016 " 0.0002 0.0001 
0.0413 
0.0023 0.0003 0.0000 
0.0201 0.0152 
0.0131 0.0221 
SEM,, Standard error of the mean; ANOVA, analysis of variance; CA, circulatory arrest; POD, postoperative day; Ca, calcium. 
hematocrit among groups before operation. During 
the cooling, arrest, and rewarming phases of CPB, 
there were no statistical differences in esophageal 
temperature among groups. During the cooling 
phase, hematocrit was set according to protocol, but 
there were no differences among groups after re- 
warming and on the first postoperative day. The 
mean perfusion pressure and calcium concentration 
changed with the hematocrit level during cooling 
and were therefore highest in group 3 and lowest in 
group 1 (p < 0.0001). The osmolarity of the pump 
prime was significantly lower in group I, but there 
were no significant differences among groups after 
rewarming and discontinuation of CPB. 
Operative results. Two of seven animals in the 
extreme hemodilution group (group 1) developed 
severe hypotension and low-output state after wean- 
ing from CPB and could not be resuscitated. All 
data from these two animals were excluded from 
subsequent analysis. All other animals were extu- 
bated within 24 hours of operation and survived 
until postoperative day 4, when they were sacrificed 
for histologic examination. 
Cerebral high-energy phosphates and intracellu- 
lar pH (PHi). During the cooling phase a significant 
decrease in phosphocreatine (PCr) in group I was 
noted during the initial 10 and 20 minutes, whereas 
PCr increased in groups II and III (Fig. 2). An 
increase in pH i was noted in group III, whereas pH i 
significantly decreased during cooling in group I. 
During the circulatory arrest period, the adenosine 
triphosphate (ATP) signal was highest in group III 
and lowest in group I. PCr and pH i did not show any 
significant differences among groups during DHCA. 
During the rewarming phase, group III showed 
more rapid recovery of ATP, PCr, and pH i than in 
groups I and II. After discontinuation of CPB 
bypass, group III maintained higher levels of ATP, 
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Fig. 2. Results of MRS. A, Cerebral ATP; B, cerebral PCr; C, cerebral pH i. 
350 
PCr, and pH i than did groups I and II. Three hours 
after CPB, however, there were no significant dif- 
ferences among groups with respect o PCr and pHi, 
although group I I I  showed a significantly higher 
ATP level than did group I. 
NIRS. The oxyhemoglobin signal increased sig- 
nificantly during cooling in the whole-blood prime 
group (group III; Fig. 3). During cooling, the redox 
state of cytochrome aa 3 increased in group II I  but 
decreased significantly in groups I and II (Fig. 3). 
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Fig. 3. Results of NIRS. A, Oxyhemoglobin; B, deoxyhemoglobin. DPF, Differential pathlength factor. 
From the onset of DHCA, there was a decline in 
oxyhemoglobin and cytochrome aa3 signals in all 
groups, and deoxyhemoglobin creased recipro- 
cally. In group I and II, however, oxyhemoglobin 
and deoxyhemoglobin reached plateaus within ap- 
proximately 30 minutes, whereas in group III there 
was no plateau in either signal. 
Enzymes. There were no statistically significant 
differences among the three experimental groups 
(Table II). Levels of CK, AST, ALT, LDH, ALP, 
and total bilirubin tended to be lowest in group III. 
Nenrologic deficit score. The NDS and OPC 
demonstrated more rapid recovery in group III than 
in groups I and II (Table II). On postoperative day 
1, both the NDS and OPC in group III were 
significantly better than those in group II (p = 
0.0965 for NDS, p -- 0.0194 for OPC). On postop- 
erative 2, the NDS in group IH remained signifi- 
cantly better than that in group II (p = 0.0492). The 
NDS was generally worse in group I than group III, 
although this difference did not reach statistical 
significance. By postoperative days 3 and 4, most 
animals had recovered and showed normal perfor- 
mance, with no neurologic deficit. 
Neuropathologic results. As in previous tudies, 
neuropathologic damage was evaluated primarily by 
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the presence of hypereosinophilic shrunken eurons 
with karyorrhectic nuclei, suggestive of recent hy- 
poxic ischemic injury (Fig. 4). The patterns of injury 
followed those seen in the previous studies. Injury 
occurred primarily in the lateral frontal and parietal 
neocortex. A lesser degree of damage was present in 
the caudate nucleus; in one instance, a focal isch- 
emic lesion of grade 2 was present in the hippocam- 
pal dentate gyrus. No damage that could be ascribed 
to hypoxic or ischemic injury was noted in the 
diencephalon, brain stem, or cerebellum. Rare, scat- 
tered perivascular vacuolated lesions were noted, 
but these were not systematically recorded and their 
significance remains unclear at present. The hypoxic 
or ischemic injury was most pronounced in group I 
and was negligible in groups II and III (Fig. 5). 
Discussion 
In this study, a blood-free prime r sulting in a 
hematocrit lower than 10% was associated with 
evidence of inadequate oxygen delivery to cerebral 
cells, as suggested by reduced cytochrome aa~ by 
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Table II. Results 
Group I 
(mean ± SEM) 
Significant difference 
(p < o.os) 
Group II Group I l l  ANOVA p 
(mean ± SEM (mean -- SEM) K-W test I vs11 H vs111 111vs1 
Neurologic scores 
NDS 
POD1 95.83 ± 18.73 
POD2 24.17 ± 12.68 
POD3 3.33 ± 3.65 
POD4 0.00 ± 0.00 
OPC 
POD1 2.67 ± 0.23 
POD2 1.33 ± 0.23 
POD3 1.00 ± 0.00 
POD4 1.00 ± 0.00 
Enzymes 
AST 132.60 ± 18.95 
ALT 31.00 -- 5.52 
LDH 1125.60 ± 85.89 
ALP 157.80 2 16.00 
CK 4008.20 + 483.76 
TB 0.42 ± 0.04 
Histology 
Neocortex 1.33 .. 0.33 
Hippocampus 0.25 ± 0.25 
Caudate 1.00 ± 0.71 
112.50 ± 14.54 58.00 ± 7.52 0.0465 0.0077 
39.17 ± 11.87 4.00 ± 4.00 0.0492 0.0213 
3.33 ± 3.65 0.00 ± 0.00 0.6702 
0.00 ± 0.00 0.00 ± 0.00 NA 
3.00 _+ 0.00 2.00 ± 0.00 0.0194 
1.83 ± 0.34 1.00 ± 0.00 0.1588 
1.00 _+ 0.00 1.00 ± 0.00 NA 
1.00 ± 0.00 1.00 ± 0.00 NA 
119.40 ± 13.40 95.40 ± 11.41 0.1917 
34.00 ± 3.61 28.80 ± 2.48 0.6190 
1228.50 ± 171.58 959.00 ± 114.75 0.2798 
165.75 + 17.31 202.20 ± 10.17 0.0700 
3471.80 .. 607.08 2977.60 ± 831.51 0.5255 
0.43 ± 0.19 0.28 ± 0.07 0.4855 
0.22 ± 0.11 0.40 ± 0.18 
0.00 ± 0.00 0.00 ± 0.00 
0.17 ± 0.17 0.00 -+ 0.00 
0.0422 
0.0287 0.0054 0.0225 
SEM,, standard error of the mean; ANOVA, analysis of variance; K-W, Kruskal-Wallis; POD, postoperative day; TB, total bilirubin. 
NIRS during the cooling phase on CPB before 
DHCA. Furthermore, cerebral PCr and pH i fell 
significantly during cooling with severe hemodilu- 
tion. Histologic assessment revealed neuronal ne- 
crosis after 4 days. In contrast, a hematocrit greater 
than 30 was associated with increased mitochondrial 
oxygen availability during cooling. In addition, oxy- 
hemoglobin was markedly above baseline at the 
onset of DHCA, followed by a continuous decline 
during DHCA. This suggests that red blood cells 
continue to deliver oxygen throughout the arrest 
period; that is, hemoglobin may act as a reservoir of 
oxygen through 1 hour of DHCA. In contrast, 
oxyhemoglobin remained at baseline through cool- 
ing with a hematocrit lower than 10%. During 
DHCA, it appears that the oxygen reservoir is 
exhausted after approximately 30minutes when the 
hematocrit is 20% or lower than 10%. The findings 
with oxyhemoglobin are reinforced by the reciprocal 
changes observed with deoxyhemoglobin, as mea- 
sured by NIRS. 
The least evidence of neurologic injury was ob- 
served in the animals with the highest hematocrits. 
The greatest histologic damage was seen in the 
animals with the lowest hematocrits. 
The findings of this study are consistent with 
previous work from this laboratory, which suggested 
that a more alkaline pH strategy (alpha-stat) during 
cooling before DHCA with moderate hemodilution 
(hematocrit 20%) is associated with a greater degree 
of mitochondrial hypoxia, delayed recovery of cere- 
bral high-energy phosphates, and worse neurodevel- 
opmental outcome than is a more acidotic strategy 
(pH_stat).11, 4In the setting of deep hypothermia 
with severe or moderate hemodilution, this study 
suggests that hematocrit critically limits oxygen de- 
livery. A more alkaline pH strategy further limits 
oxygen delivery through its effect on oxyhemoglobin 
dissociation. 
It is interesting to speculate why the neurologic 
recovery of the moderate hemodilution group was 
delayed relative to the highest and lowest hemato- 
crit groups. The moderate hemodilution group had 
no colloid added to the prime, whereas the severe 
hemodilution group had hetastarch added to model 
the addition of albumin, as is done clinically by the 
Loma Linda group. The colloid osmotic pressure 
was thus almost certainly higher in groups I and III 
than in group II. This may have been associated with 
more cerebral as well as generalized body edema in 
group II, which may have resulted in worse neuro- 
logic and general performance scores. We are cur- 
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Fig. 4. A, Frontal neocortex (×40) from group I showing 
area of hypoxic-ischemic injury. This mo t severely injured 
animal in this group would be scored as having 2+lesion. 
Note several neurons with hypereosinophic cytoplasm and 
karyorrhectic nuclei (arrows). Blood vessel in upper right 
corner shows no pathologic hange. B, Hippocampal 
pyramidal cell layers (from same animal as in A) showing 
no damage (×20). C, Fascia dentata (from same animal as 
A) showing no damage (×20). D, Fascia of hypoxic- 
ischemic damage between arrows. This animal had less 
injury to neocortex than did the other animal in this figure. 
No evidence of capillary damage or microemboli was 
present. (7 t~m paraffin sections; 
rently undertaking a study that will separate the 
effects of red blood cell and colloid hemodilution. 
This should help to define the relative importances 
of the inadequate oxygen delivery demonstrated by
the intraoperative MRS and NIRS and of postoper- 
ative edema in determining postoperative outcome. 
There has been a long-standing controversy re- 
garding the optimal degree of hemodilution during 
hypothermic CPB. 15' 16 Kawashima, Yamamoto, and 
Manabe ~7 and Michenfelder and Theye 18 found that 
oxygen delivery was limited by a hematocrit lower 
than 20%. A lower hematocrit resulted in acidosis. 
In 1976, Koster and coworkers I9 demonstrated the 
beneficial effects of hemodilution on cerebral blood 
flow. In studies of three experimental groups with 
various degrees of hemodilution on CPB at hemat- 
ocrits of 40%, 25%, and 15%, they concluded that 
hemodilution enhanced cerebral blood flow and 
maintained oxygen delivery to the brain in the dog. 
After 60 minutes of arrest, there was significant 
cerebral hyperemia during reperfusion, especially in 
the hemodilution group. This finding has been sub- 
stantiated by many other investigators. 2°-22 It can be 
argued, however, that there is a serious limitation to 
studies that derive inferences from cerebral blood 
flow and metabolic rate determined by oxygen con- 
sumption in any setting where oxyhemoglobin dis- 
sociation is shifted leftward, as is the case with 
hypothermic CPB, particularly profoundly hypo- 
thermic CPB. There are even more important limi- 
tations to the many studies that have examined the 
question of optimal hematocrit with non-CPB mod- 
els. 21 In these models, hemodilution is always com- 
pensated for by a marked increase in cardiac output, 
usually also associated with an increase in cerebral 
blood flow. It is not clear whether the increases in 
cardiac output and cerebral blood flow are related 
to the decrease in viscosity caused by hemodilution 
or if there is an important component of hypoxic 
stress (flow-metabolism coupling in the case of the 
brain) that drives the increase in flow. In any event, 
cardiac output is fixed in the patient receiving CPB. 
Furthermore, the flow rate that is traditionally used 
at normothermia (2 to 2.5 L .  rain -1 • m -2) would 
be considered a low cardiac output state in a nor- 
mothermic person with a normal hematocrit. This 
could not be considered a flow rate that might 
compensate for the effects of hemodilution. Never- 
theless, clinical experience suggests that hemodilu- 
tion to a hematocrit between 20% and 30% in the 
adult undergoing continuous mildly or moderately 
hypothermic CPB is not associated with neurologic 
injury, 6 although comprehensive n uropsychometric 
testing has only recently been widely employed. One 
multiinstitutional study of adults found that lower 
hematocrit was associated with a postoperative de- 
crease in cognitive score. 23 
The effects of deep hypothermia on microvascular 
circulation are complex and include red blood cell 
aggregation and arteriovenous shunting. 24 The role 
of hemodilution i reversing these effects was re- 
viewed by Cooper and Elliott. 4 Edmunds and asso- 
ciates 25 suggested that the presence of microinfarc- 
tion observed from sections of the brain taken from 
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Fig. 5. Histologic score for neocortex, hippocampus, and caudate nucleus. 
animals subjected to DHCA was related to the 
presence of blood within the brain during the period 
of DHCA. In a study in our laboratory with a 
blood-free solution (Hypothermosol; Cryomedical 
Sciences, Rockville, Md.) in the cerebral circulation 
during DHCA, however, outcome as determined by 
NIRS and by neurologic score was inferior to out- 
come with blood perfusate. 13This study revealed no 
histologic evidence of microinfarcts. Most previous 
studies of microcirculatory disturbance in the setting 
of DHCA predate more recent interest in endothe- 
lial and white blood cell activation and its relation- 
ship to ischemia. 26 Future studies hould focus on 
the role of upregulation of adhesion molecules in 
contributing to microcirculatory disturbance after 
DHCA. The role of red blood cell aggregation may 
have been overemphasized. 
This is the first study from our laboratory that has 
combined MRS and NIRS with postoperative n u- 
rologic evaluation and histologic assessment in the 
same animals. We hoped to identify changes in 
intraoperative MRS and NIRS parameters that best 
predicted neurologic and histologic outcomes, and 
we therefore calculated Pearson coefficients. Al- 
though no definite predictors were identified, it is 
interesting to note the trends in r and p values. For 
example, for ATP at DHCA 60 minutes versus NDS 
on day 1, p was 0.98; for cytochrome aa 3 at DHCA 
60 minutes versus NDS on day 1, p was 0.2; for pH 
at DHCA 60 minutes versus NDS on day 1, p was 
0.12. The lack of statistically significant predictors i
perhaps not surprising in light of the small numbers 
and the fact that DHCA time was limited to mini- 
mize mortality, rather than being extended to 
achieve severe neurologic injury as has been done in 
some previous tudies from our laboratory. 
In conclusion, extreme hemodilution results in 
evidence of inadequate oxygen delivery during the 
initial cooling phase and during DHCA. Whole- 
blood priming is associated with optimal preserva- 
tion of mitochondrial redox state, optimal preserva- 
tion of high-energy phosphates, and subsequently 
better early neurologic and histologic scores. The 
improved cerebral recovery with higher hematocrit 
after DHCA might in part be explained by greater 
oxygen availability and therefore preservation of 
high-energy phosphate metabolism. However, the 
effects of cerebral edema, low perfusion pressure, 
and low colloid oncotic pressure related to hemodi- 
lution could also be important. Further studies are 
underway to explore these variables. 
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Discussion 
Dr. Steven R. Gundry (Loma Linda, Calif.). I congrat- 
ulate you on designing a complex experimental model to 
once again look at the outcomes of various protocols for 
circulatory arrest. The fact that you were able to carry out 
this experiment successfully in a large number of piglets 
reflect your skills as surgeons and as managers of a bypass 
circuit. 
You have attempted tocompare three clinical protocols 
that are in use at Loma Linda, Boston, and Paris by means 
of three distinct methods of hemodilution orpriming with 
whole blood. You have come to a remarkable conclusion 
in that you have concluded that your own protocol was not 
the winner, and you, the authors, are to be congratulated 
on admitting that. A review of the details of your perfu- 
sion mechanism, however, suggests that your conclusions 
are correct but your method of arriving at the conclusions 
may in fact be incorrect, and that you set yourself up to 
make the high hematocrit group win. 
Specifically, I have these comments. You note in your 
article that the aortic cannula was placed in the femoral 
artery. This is far removed from the brain and completely 
opposite to the method used clinically, where the aortic 
cannula nd thus the perfusate visit the brain first rather 
than last. This ensures that the brain is the last organ to be 
cooled in your model, rather than the first, as is done 
clinically. 
Next, I noticed that your cooling occurs during a 
40-minute period, and you specifically relate in your 
article that you used the entire 40 minutes to reach the 
cooling temperature. This implies that for most of the 
40-minute cooling period the two groups with very low 
hemoglobin do in fact have very low oxygen-carrying 
capacity during periods of relative warmth of the brain. 
Your conclusions are therefore correct that during a 
prolonged, slow cooling period, the two groups that have 
the least oxygen carrying capacity and the slowest cooling 
of the brain would lose in this protocol, and that is exactly 
what you prove. Clinical protocols are exactly the oppo- 
site. The brain cannula is nearby and the brain is cooled 
rapidly, at Loma Linda specifically during a 10-minute 
period. Work by Schell and colleagues at Duke has shown 
fairly conclusively that rapid cooling of the brain results in 
much better brain metabolism after these short cooling 
periods compared with a long period for cooling of the 
brain. 
Finally, I noticed that your group I was primed with 
hetastarch. Schell and colleagues at Duke have shown 
repeatedly that hetastarch undergoes viscosity changes at 
low temperatures. Specifically, hetastarch is not used in a 
priming solution at Loma Linda or at any other institution 
that I know of for circulatory arrest. I think that the fact 
that two animals out of the group I group died of 
hypotension suggests that this model was not tolerated 
systemically, either with the heart or any other organ, 
much less the brain; thus you set this model up to lose. 
I have two questions. Do you believe that a more 
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clinically relevant cannulation and cooling period would 
have changed your results, and perhaps that your own 
method of cooling would then have prevailed? 
Second, do you think that the fact that two animals in 
group I died of hypotension suggests that the hetastarch, 
which is not used in any clinical protocol, may have been 
the reason for some of your findings? 
I again congratulate you on a difficult study, but I think 
examination of your protocol shows what you might 
expect--a lot of blood with warm temperatures is better 
than no blood at warm temperatures. 
Dr. Shin'oka. Thank you, Dr. Gundry. In response to 
the first issue, regarding the site of arterial cannulation, 
we do not agree that femoral cannulation would bias the 
result against the low-hematocrit groups. In fact, we 
believe it possible that the bias would be in the opposite 
direction, for the following reason. The fundamental 
problem in the low-hematocrit groups is that there is 
inadequate oxygen carrying capacity in the early phase of 
cooling, as demonstrated by reduction in the cytochrome 
aa3 signal and fall in PCr level. This is because of 
inadequate oxygen delivery from a low-hematocrit perfus- 
ate when the brain is still warm and the perfusate is cold. 
The more gradual cooling of the brain that results from 
femoral cannulation should, if anything, decrease this 
problem in the low-hematocrit groups. 
Regarding the cooling duration of 40 minutes, we 
believe that the same issue applies here. In other words, a 
longer cooling duration allows any oxygen debt incurred 
in the early phase of cooling to be "paid off." We suspect 
that if a shorter cooling duration had been employed, the 
differences between the groups would have been exagger- 
ated. 
Finally, regarding the use of hetastarch, we have been 
interested in the work of Zikria and Oz at Columbia 
University regarding the biophysical properties of 
hetastarch when used during CPB and especially during 
DHCA. The group at Columbia uses hetastarch routinely 
in their CPB prime. They have demonstrated that not only 
is the use of hetastarch not deleterious during deep 
hypothermic circulatory arrest in the piglet model but in 
fact it is associated with a marked decrease in postoper- 
ative edema. Our inference from the deaths of two 
animals in the very low-hematocrit group, with no deaths 
in the other two groups, is therefore, that this is more 
likely related to inadequate oxygen delivery not only to 
the brain but also to other organs including the heart. We 
believe that the marked reduction of the cytochrome aa 3 
signal in the low-hematocrit group as well as the fall in 
PCr is convincing evidence that extreme hemodilution 
results in inadequate oxygen availability during the early 
phases of cooling on CPB. 
